OpenBilldrug price receipt

NADAC week of 2026-10-14

NEBIVOLOL 2.5 MG TABLET

For 30 tablets

Pharmacies pay

$3.51 filed

30 × $0.11695 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$23.67 filed

30 × $0.78896 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

6.7× estimated

Medicare paid 6.7× what pharmacies pay.

Part D averages every strength and form sold under “Nebivolol HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$9.04 estimated

$3.51 + $0.53 (15%) + $5.00 fee per fill = $9.04

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

NEBIVOLOL 2.5 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “nebivolol” and “nebivolol hydrochloride”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as tablet and its route as oral.

FDA lists 12 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, Apnar Pharma LP and Unichem Pharmaceuticals (USA), Inc.

FDA’s Established Pharmacologic Class for it is beta-Adrenergic Blocker.

The NADAC file of 2026-10-14 prices it under 15 NDCs (National Drug Codes); the FDA directory lists 14 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $3.51 for 30 tablets (30 × $0.11695 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 12 labelers

LabelerNDCsPharmacies pay per unit
ANI Pharmaceuticals, Inc.2$0.11695 per EA filed
Apnar Pharma LP2$0.11695 per EA filed
Ascend Laboratories, LLC1$0.11695 per EA filed
Aurobindo Pharma Limited1$0.11695 per EA filed
Camber Pharmaceuticals, Inc.1$0.11695 per EA filed
Macleods Pharmaceuticals Limited1$0.11695 per EA filed
Major Pharmaceuticals1$0.11695 per EA filed
Modavar Pharmaceuticals LLC1$0.11695 per EA filed
NorthStar RxLLC1$0.11695 per EA filed
Novadoz Pharmaceuticals LLC1$0.11695 per EA filed
Solco Healthcare US, LLC1$0.11695 per EA filed
Unichem Pharmaceuticals (USA), Inc.1$0.11695 per EA filed
Not listed as a package in the FDA directory1$0.11695 per EA filed
All 15 NDCs, with labeler and price
  • 00904-7497-04 · Major Pharmaceuticals · $0.11695 per EA · eff. 2026-09-23 filed
  • 13668-0353-30 · not listed as a package in the FDA directory · $0.11695 per EA · eff. 2026-09-23 filed
  • 24689-0159-01 · Apnar Pharma LP · $0.11695 per EA · eff. 2026-09-23 filed
  • 24689-0159-02 · Apnar Pharma LP · $0.11695 per EA · eff. 2026-09-23 filed
  • 29300-0375-13 · Unichem Pharmaceuticals (USA), Inc. · $0.11695 per EA · eff. 2026-09-23 filed
  • 31722-0585-30 · Camber Pharmaceuticals, Inc. · $0.11695 per EA · eff. 2026-09-23 filed
  • 33342-0457-07 · Macleods Pharmaceuticals Limited · $0.11695 per EA · eff. 2026-09-23 filed
  • 43547-0524-03 · Solco Healthcare US, LLC · $0.11695 per EA · eff. 2026-09-23 filed
  • 59651-0137-30 · Aurobindo Pharma Limited · $0.11695 per EA · eff. 2026-09-23 filed
  • 62559-0275-30 · ANI Pharmaceuticals, Inc. · $0.11695 per EA · eff. 2026-09-23 filed
  • 62559-0275-83 · ANI Pharmaceuticals, Inc. · $0.11695 per EA · eff. 2026-09-23 filed
  • 67877-0393-30 · Ascend Laboratories, LLC · $0.11695 per EA · eff. 2026-09-23 filed
  • 72205-0150-30 · Novadoz Pharmaceuticals LLC · $0.11695 per EA · eff. 2026-09-23 filed
  • 72241-0032-22 · Modavar Pharmaceuticals LLC · $0.11695 per EA · eff. 2026-09-23 filed
  • 72603-0870-01 · NorthStar RxLLC · $0.11695 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

7 other products in the NADAC file share an FDA nonproprietary name with NEBIVOLOL 2.5 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
BYSTOLIC 2.5 MG TABLET
brand · tablet
$6.4462 per EA filed
eff. 2026-09-23
$5.74203 per EA filed
Part D 2024 average
BYSTOLIC 5 MG TABLET
brand · tablet
$6.45128 per EA filed
eff. 2026-09-23
$5.74203 per EA filed
Part D 2024 average
BYSTOLIC 10 MG TABLET
brand · tablet
$6.40917 per EA filed
eff. 2026-09-23
$5.74203 per EA filed
Part D 2024 average
BYSTOLIC 20 MG TABLET
brand · tablet
$6.42189 per EA filed
eff. 2026-09-23
$5.74203 per EA filed
Part D 2024 average
NEBIVOLOL 2.5 MG TABLET this page
generic · tablet
$0.11695 per EA filed
eff. 2026-09-23
$0.78896 per EA filed
Part D 2024 average
NEBIVOLOL 5 MG TABLET
generic · tablet
$0.11337 per EA filed
eff. 2026-09-23
$0.78896 per EA filed
Part D 2024 average
NEBIVOLOL 10 MG TABLET
generic · tablet
$0.14144 per EA filed
eff. 2026-09-23
$0.78896 per EA filed
Part D 2024 average
NEBIVOLOL 20 MG TABLET
generic · tablet
$0.17489 per EA filed
eff. 2026-09-23
$0.78896 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 15 NDCs’ NADAC prices is $0.11695 per EA filed.

Of the 76 other products in FDA’s beta-Adrenergic Blocker class priced per EA, 56 have a higher middle NADAC price and 20 a lower one. The one in the middle is NADOLOL 40 MG TABLET, at $0.26544 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $23.67 for 30 tablets, at an average of $0.78896 per EA in 2024 (2024-01-01 to 2024-12-31) for “Nebivolol HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 1,387,136 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for NEBIVOLOL 2.5 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Nebivolol HCl / Nebivolol HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.